Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy

Blood Cancer J. 2019 Aug 20;9(9):68. doi: 10.1038/s41408-019-0227-3.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • E-Selectin / genetics*
  • Female
  • Humans
  • Male
  • Multiple Myeloma / genetics*
  • Multiple Myeloma / pathology
  • Receptors, CXCR4 / genetics*

Substances

  • CXCR4 protein, human
  • E-Selectin
  • Receptors, CXCR4